TY - JOUR
T1 - Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization
AU - Uzan-Yulzari, Atara
AU - Turta, Olli
AU - Belogolovski, Anna
AU - Ziv, Oren
AU - Kunz, Christina
AU - Perschbacher, Sarah
AU - Neuman, Hadar
AU - Pasolli, Edoardo
AU - Oz, Aia
AU - Ben-Amram, Hila
AU - Kumar, Himanshu
AU - Ollila, Helena
AU - Kaljonen, Anne
AU - Isolauri, Erika
AU - Salminen, Seppo
AU - Lagström, Hanna
AU - Segata, Nicola
AU - Sharon, Itai
AU - Louzoun, Yoram
AU - Ensenauer, Regina
AU - Rautava, Samuli
AU - Koren, Omry
N1 - Publisher Copyright: © 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Exposure to antibiotics in the first days of life is thought to affect various physiological aspects of neonatal development. Here, we investigate the long-term impact of antibiotic treatment in the neonatal period and early childhood on child growth in an unselected birth cohort of 12,422 children born at full term. We find significant attenuation of weight and height gain during the first 6 years of life after neonatal antibiotic exposure in boys, but not in girls, after adjusting for potential confounders. In contrast, antibiotic use after the neonatal period but during the first 6 years of life is associated with significantly higher body mass index throughout the study period in both boys and girls. Neonatal antibiotic exposure is associated with significant differences in the gut microbiome, particularly in decreased abundance and diversity of fecal Bifidobacteria until 2 years of age. Finally, we demonstrate that fecal microbiota transplant from antibiotic-exposed children to germ-free male, but not female, mice results in significant growth impairment. Thus, we conclude that neonatal antibiotic exposure is associated with a long-term gut microbiome perturbation and may result in reduced growth in boys during the first six years of life while antibiotic use later in childhood is associated with increased body mass index.
AB - Exposure to antibiotics in the first days of life is thought to affect various physiological aspects of neonatal development. Here, we investigate the long-term impact of antibiotic treatment in the neonatal period and early childhood on child growth in an unselected birth cohort of 12,422 children born at full term. We find significant attenuation of weight and height gain during the first 6 years of life after neonatal antibiotic exposure in boys, but not in girls, after adjusting for potential confounders. In contrast, antibiotic use after the neonatal period but during the first 6 years of life is associated with significantly higher body mass index throughout the study period in both boys and girls. Neonatal antibiotic exposure is associated with significant differences in the gut microbiome, particularly in decreased abundance and diversity of fecal Bifidobacteria until 2 years of age. Finally, we demonstrate that fecal microbiota transplant from antibiotic-exposed children to germ-free male, but not female, mice results in significant growth impairment. Thus, we conclude that neonatal antibiotic exposure is associated with a long-term gut microbiome perturbation and may result in reduced growth in boys during the first six years of life while antibiotic use later in childhood is associated with increased body mass index.
UR - http://www.scopus.com/inward/record.url?scp=85099797573&partnerID=8YFLogxK
U2 - https://doi.org/10.1038/s41467-020-20495-4
DO - https://doi.org/10.1038/s41467-020-20495-4
M3 - مقالة
C2 - 33500411
SN - 2041-1723
VL - 12
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 443
ER -